Paris Saclay Seed Fund backed a series A round which will help the biotechnology company expand sales and launch a new product.
France-based DNA quantification company Stilla Technologies has raised €16m ($18m) in a series A round backed by Paris Saclay Seed Fund, a university venture fund formed by University of Paris-Saclay.
Illumina Ventures, the corporate venturing arm of genomics technology producer Illumina, led the round, which also featured financial services firm BNP Paribas through its BNP Paribas Développement unit.
Healthcare-focused investment firm Kurma Partners and private equity firms Idinvest Partners and LBO France filled out the round.
Founded…
